March 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acuity Brands, CSG Systems International and Nuvation Bio, on Wednesday.
HIGHLIGHTS
* Acuity Brands Inc : Baird raises target price to $286 from $236
* CSG Systems International : RBC initiates coverage with outperform rating
* Lenz Therapeutics Inc : Piper Sandler initiates coverage with overweight rating
* Nuvation Bio Inc : Jefferies raises to buy from hold
* Transdigm Group Inc : JP Morgan raises target price to $1,175 from $1,050
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Acuity Brands Inc : Baird raises target price to $286 from $236
* Acumen Pharmaceuticals Inc : BTIG cuts target price to $11 from $22
* Annexon Inc : Jefferies raises target price to $10 from $8.5
* Aprea Therapeutics Inc : Wedbush raises target price to $11 from $9
* Arch Resources Inc : Jefferies cuts target price to $185 from $190
* Bluebird Bio Inc : Raymond James cuts target price to $7 from $13
* Bluebird Bio Inc : Wedbush raises target price to $1.72 from $1.68
* Celsius Holdings Inc : Jefferies raises target price to $107 from $105
* CSG Systems International : RBC initiates coverage with outperform rating
* CSG Systems International : RBC initiates target price $61
* Dow Inc : Jefferies raises target price to $60 from $56
* Getty Realty Corp : JP Morgan cuts target price to $31 from $32
* Immunome Inc : Leerink Partners cuts target price to $38 from $40
* International Flavors & Fragrances : Morgan Stanley raises PT to $96 from $89
* Korro Bio Inc : RBC raises target price to $90 from $70
* Lenz Therapeutics Inc : Piper Sandler initiates coverage with overweight rating
* Lenz Therapeutics Inc : Piper Sandler initiates target price $28
* Mastercard Inc : Evercore ISI raises target price to $545 from $530
* McCormick & Company Inc : Jefferies raises target price to $77 from $67
* McCormick & Company Inc : TD Cowen raises target price to $75 from $67
* Merck & Co Inc : Jefferies raises target price to $145 from $140
* Nexpoint Real Estate Finance Inc : Raymond James cuts PT to $17 from $19
* Nuvation Bio Inc : Jefferies raises to buy from hold
* Nuvation Bio Inc : Jefferies raises target price to $10 from $1.4
* Praxis Precision Medicines Inc : Jefferies raises PT to $128 from $75
* Progress Software Corp : JP Morgan cuts target price to $63 from $65
* Realty Income Corp : JP Morgan cuts target price to $60 from $64
* TD Synnex Corp : Raymond James raises target price to $125 from $120
* TD Synnex Corp : RBC raises target price to $118 from $110
* Third Harmonic Bio Inc : Jefferies raises target price to $8.1 from $3.6
* Transdigm Group Inc : JP Morgan raises target price to $1,175 from $1,050
* United Therapeutics Corp : Leerink Partners raises PT to $335 from $330
* UPS : Jefferies cuts target price to $175 from $180
* Viking Therapeutics Inc : Leerink Partners raises PT to $115 from $105
* Viking Therapeutics Inc : Oppenheimer raises target price to $138 from $116
* Visa Inc : Evercore ISI raises target price to $335 from $325
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Comments